Eyes that Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proportion of the Real-World Patient Population and Reasons for Exclusion
Background. To evaluate the proportion of eyes that do not meet the eligibility criteria of clinical trials on neovascular age-related macular degeneration (AMD) and the reasons for exclusion. Methods. This retrospective, observational study included 512 eyes of 463 patients diagnosed with treatment...
Saved in:
Main Authors: | Jae Hui Kim, Jong Woo Kim, Chul Gu Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2021/6635467 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes and predictive factors for fluid resolution following three loading injections of faricimab for treatment-naïve neovascular age-related macular degeneration
by: Hee Yong Han, et al.
Published: (2025-01-01) -
Treatment for neovascular age-related macular degeneration: reasonable expectations of physicians and patients
by: A.B. Durasov
Published: (2021-09-01) -
Eligibility for faricimab in a real-world diabetic macular oedema population: a cross-sectional study
by: Helena Norberg, et al.
Published: (2025-02-01) -
Real world pharmacovigilance assessment of drug related macular degeneration risks
by: Xiaodong Chen, et al.
Published: (2025-01-01) -
Criteria of eligibility of patients with ischemic cardiomyopathy for revascularization and other surgical procedures
by: N.D. Oryshchyn
Published: (2016-09-01)